The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Brachytherapy-Global Market Insights and Sales Trends 2025
Synopsis
The global Brachytherapy market size is expected to reach US$ 419.1 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Brachytherapy in various end use industries. The expanding demands from the Prostate cancer, Gynecological cancer, Breast cancer and Other cancers, are propelling Brachytherapy market. High Dose Rate (HDR) Brachytherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Dose (LDR) Brachytherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brachytherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brachytherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brachytherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brachytherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brachytherapy covered in this report include Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Elekta AB (pub), Theragenics Corporation, C.R. Bard, Inc., CIVCO Medical Solutions, Huiheng Medical, Inc., Sun Nuclear Corporation and iCAD, Inc., etc.
The global Brachytherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eckert & Ziegler BEBIG
IsoRay Medical, Inc.
Elekta AB (pub)
Theragenics Corporation
C.R. Bard, Inc.
CIVCO Medical Solutions
Huiheng Medical, Inc.
Sun Nuclear Corporation
iCAD, Inc.
Varian Medical Systems, Inc.
Global Brachytherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brachytherapy market, Segment by Type:
High Dose Rate (HDR) Brachytherapy
Low Dose (LDR) Brachytherapy
Global Brachytherapy market, by Application
Prostate cancer
Gynecological cancer
Breast cancer
Other cancers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brachytherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Brachytherapy market size is expected to reach US$ 419.1 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Brachytherapy in various end use industries. The expanding demands from the Prostate cancer, Gynecological cancer, Breast cancer and Other cancers, are propelling Brachytherapy market. High Dose Rate (HDR) Brachytherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low Dose (LDR) Brachytherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brachytherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brachytherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brachytherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brachytherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brachytherapy covered in this report include Eckert & Ziegler BEBIG, IsoRay Medical, Inc., Elekta AB (pub), Theragenics Corporation, C.R. Bard, Inc., CIVCO Medical Solutions, Huiheng Medical, Inc., Sun Nuclear Corporation and iCAD, Inc., etc.
The global Brachytherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eckert & Ziegler BEBIG
IsoRay Medical, Inc.
Elekta AB (pub)
Theragenics Corporation
C.R. Bard, Inc.
CIVCO Medical Solutions
Huiheng Medical, Inc.
Sun Nuclear Corporation
iCAD, Inc.
Varian Medical Systems, Inc.
Global Brachytherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brachytherapy market, Segment by Type:
High Dose Rate (HDR) Brachytherapy
Low Dose (LDR) Brachytherapy
Global Brachytherapy market, by Application
Prostate cancer
Gynecological cancer
Breast cancer
Other cancers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brachytherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Brachytherapy
1.1 Brachytherapy Market Overview
1.1.1 Brachytherapy Product Scope
1.1.2 Brachytherapy Market Status and Outlook
1.2 Global Brachytherapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brachytherapy Market Size by Region (2018-2029)
1.4 Global Brachytherapy Historic Market Size by Region (2018-2023)
1.5 Global Brachytherapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brachytherapy Market Size (2018-2029)
1.6.1 North America Brachytherapy Market Size (2018-2029)
1.6.2 Europe Brachytherapy Market Size (2018-2029)
1.6.3 Asia-Pacific Brachytherapy Market Size (2018-2029)
1.6.4 Latin America Brachytherapy Market Size (2018-2029)
1.6.5 Middle East & Africa Brachytherapy Market Size (2018-2029)
2 Brachytherapy Market by Type
2.1 Introduction
2.1.1 High Dose Rate (HDR) Brachytherapy
2.1.2 Low Dose (LDR) Brachytherapy
2.2 Global Brachytherapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brachytherapy Historic Market Size by Type (2018-2023)
2.2.2 Global Brachytherapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brachytherapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brachytherapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brachytherapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brachytherapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brachytherapy Revenue Breakdown by Type (2018-2029)
3 Brachytherapy Market Overview by Application
3.1 Introduction
3.1.1 Prostate cancer
3.1.2 Gynecological cancer
3.1.3 Breast cancer
3.1.4 Other cancers
3.2 Global Brachytherapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brachytherapy Historic Market Size by Application (2018-2023)
3.2.2 Global Brachytherapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brachytherapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brachytherapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brachytherapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brachytherapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brachytherapy Revenue Breakdown by Application (2018-2029)
4 Brachytherapy Competition Analysis by Players
4.1 Global Brachytherapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brachytherapy as of 2022)
4.3 Date of Key Players Enter into Brachytherapy Market
4.4 Global Top Players Brachytherapy Headquarters and Area Served
4.5 Key Players Brachytherapy Product Solution and Service
4.6 Competitive Status
4.6.1 Brachytherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eckert & Ziegler BEBIG
5.1.1 Eckert & Ziegler BEBIG Profile
5.1.2 Eckert & Ziegler BEBIG Main Business
5.1.3 Eckert & Ziegler BEBIG Brachytherapy Products, Services and Solutions
5.1.4 Eckert & Ziegler BEBIG Brachytherapy Revenue (US$ Million) & (2018-2023)
5.1.5 Eckert & Ziegler BEBIG Recent Developments
5.2 IsoRay Medical, Inc.
5.2.1 IsoRay Medical, Inc. Profile
5.2.2 IsoRay Medical, Inc. Main Business
5.2.3 IsoRay Medical, Inc. Brachytherapy Products, Services and Solutions
5.2.4 IsoRay Medical, Inc. Brachytherapy Revenue (US$ Million) & (2018-2023)
5.2.5 IsoRay Medical, Inc. Recent Developments
5.3 Elekta AB (pub)
5.3.1 Elekta AB (pub) Profile
5.3.2 Elekta AB (pub) Main Business
5.3.3 Elekta AB (pub) Brachytherapy Products, Services and Solutions
5.3.4 Elekta AB (pub) Brachytherapy Revenue (US$ Million) & (2018-2023)
5.3.5 Theragenics Corporation Recent Developments
5.4 Theragenics Corporation
5.4.1 Theragenics Corporation Profile
5.4.2 Theragenics Corporation Main Business
5.4.3 Theragenics Corporation Brachytherapy Products, Services and Solutions
5.4.4 Theragenics Corporation Brachytherapy Revenue (US$ Million) & (2018-2023)
5.4.5 Theragenics Corporation Recent Developments
5.5 C.R. Bard, Inc.
5.5.1 C.R. Bard, Inc. Profile
5.5.2 C.R. Bard, Inc. Main Business
5.5.3 C.R. Bard, Inc. Brachytherapy Products, Services and Solutions
5.5.4 C.R. Bard, Inc. Brachytherapy Revenue (US$ Million) & (2018-2023)
5.5.5 C.R. Bard, Inc. Recent Developments
5.6 CIVCO Medical Solutions
5.6.1 CIVCO Medical Solutions Profile
5.6.2 CIVCO Medical Solutions Main Business
5.6.3 CIVCO Medical Solutions Brachytherapy Products, Services and Solutions
5.6.4 CIVCO Medical Solutions Brachytherapy Revenue (US$ Million) & (2018-2023)
5.6.5 CIVCO Medical Solutions Recent Developments
5.7 Huiheng Medical, Inc.
5.7.1 Huiheng Medical, Inc. Profile
5.7.2 Huiheng Medical, Inc. Main Business
5.7.3 Huiheng Medical, Inc. Brachytherapy Products, Services and Solutions
5.7.4 Huiheng Medical, Inc. Brachytherapy Revenue (US$ Million) & (2018-2023)
5.7.5 Huiheng Medical, Inc. Recent Developments
5.8 Sun Nuclear Corporation
5.8.1 Sun Nuclear Corporation Profile
5.8.2 Sun Nuclear Corporation Main Business
5.8.3 Sun Nuclear Corporation Brachytherapy Products, Services and Solutions
5.8.4 Sun Nuclear Corporation Brachytherapy Revenue (US$ Million) & (2018-2023)
5.8.5 Sun Nuclear Corporation Recent Developments
5.9 iCAD, Inc.
5.9.1 iCAD, Inc. Profile
5.9.2 iCAD, Inc. Main Business
5.9.3 iCAD, Inc. Brachytherapy Products, Services and Solutions
5.9.4 iCAD, Inc. Brachytherapy Revenue (US$ Million) & (2018-2023)
5.9.5 iCAD, Inc. Recent Developments
5.10 Varian Medical Systems, Inc.
5.10.1 Varian Medical Systems, Inc. Profile
5.10.2 Varian Medical Systems, Inc. Main Business
5.10.3 Varian Medical Systems, Inc. Brachytherapy Products, Services and Solutions
5.10.4 Varian Medical Systems, Inc. Brachytherapy Revenue (US$ Million) & (2018-2023)
5.10.5 Varian Medical Systems, Inc. Recent Developments
6 North America
6.1 North America Brachytherapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Brachytherapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brachytherapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brachytherapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brachytherapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brachytherapy Market Dynamics
11.1 Brachytherapy Industry Trends
11.2 Brachytherapy Market Drivers
11.3 Brachytherapy Market Challenges
11.4 Brachytherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
